In recent years, there has been considerable progress in our understanding of the treatment and diagnosis of cancer, leading to the development and availability of an increasing array of novel therapies. Concurrently, there has also been an increase in understanding and insight gained into effective management strategies in cancer supportive care which have enabled oncologists to reduce the adverse impact of cancer and its treatment. However, challenges, controversies and educational gaps remain. This concise yet comprehensive pocket guide provides oncologists and other healthcare professionals with essential, evidence-based guidance on the all major elements related to cancer supportive care, including pain management and end-of-life care. Edited by a world renowned oncologist, this volume outlines complex management issues common in cancer supportive care, including metabolic emergencies, febrile neutropenia, and spinal cord compression.
SERIES OVERVIEW
The Oxford American Mini-Handbooks are a series of concisely-formatted adaptations of Oxford American Handbooks. They provide a focused and succinct summary on a specific area of a particular discipline, serving as a portable, easily accessible resource at the point of care. These smaller volumes capture the essentials of assessment and treatment in an exceptionally affordable and more clinically relevant format. Featuring useful tables and bulleted lists, these books provide a readily available resource to specialists and general practitioners alike.
Chapter 1: Introduction: Molecular Cancer Pathology
Chapter 2: Molecular alterations in cancer
Chapter 3: Cancer biology
Chapter 4: Acute myeloid leukemia (AML)
Chapter 5: Acute lymphoblastic leukemia (ALL)
Chapter 6: Chronic myeloid leukemia (CML)
Chapter 7: Myelodysplastic syndromes (MDS)
Chapter 8: Chronic lymphoid leukemias
Chapter 9: Multiple myeloma
Chapter 10: Hodgkin lymphoma (HL)
Chapter 11: Non-Hodgkin lymphomas (NHL)
Chapter 12: Follicular lymphoma international prognostic index (FLIPI)
Chapter 13: Non-Hodgkin lymphoma and acquired immunodeficiency disorder
Chapter 14: Treatment and Management for Hematological Malignancies
Chapter 15: Targeted therapies
Professor of Medicine,
Director, Health Services and Outcomes Research
Division of Medical Oncology
Duke University Medical Center and
The Duke Comprehensive Cancer Center